ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2412

Assessment and Comparison of Responsiveness of Four Patient Reported Outcome Measures to Assess Physical Function in Patients with Knee Osteoarthritis: WOMAC-PF Subscale Responds Best

Elien A.M. Mahler1, Nienke Cuperus2, Johannes W J Bijlsma3, Thea Vliet Vlieland4, Frank H.J. van den Hoogen5, Alfons den Broeder5 and Cornelia H.M. van den Ende1, 1Department of Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands, 2Rheumatology Department, Sint Maartenskliniek, Nijmegen, Netherlands, 3Rheumatology and Clinical Immunology, ARC Amsterdam; UMC Utrecht, Utrecht, Netherlands, 4Rheumatology, Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 5Rheumatology, Sint Maartenskliniek, Nijmegen, Netherlands

Meeting: 2015 ACR/ARHP Annual Meeting

Date of first publication: September 29, 2015

Keywords: Epidemiologic methods, Knee, Osteoarthritis, outcome measures and physical function

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 10, 2015

Title: Osteoarthritis - Clinical Aspects Poster II: Biomarkers, Biomechanics and Health Services Research

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose:

Although physical function is one of the core outcome domains in knee osteoarthritis (OA), the ability of a measurement instrument to detect changes over time in the construct (physical function) being measured, i.e. the responsiveness, has never been tested as currently recommended by the Consensus-based Standards for the selection of health status Measurement Instruments (COSMIN)1. The aim of the current study was to compare the responsiveness of physical function between four commonly used disease-specific patient related outcome measures in patients with knee OA following currently recommended standards.

Methods:

Patients with knee OA fulfilling the clinical ACR criteria and receiving conservative treatment following a stepped care approach were invited to complete a set of questionnaires at baseline and three months. Questionnaires included four commonly used measures of physical function ie Knee Injury and Osteoarthritis Outcome Function Short Form (KOOS-PS), the Lequesne Algofunctional index (LAI), Lower Extremity Functional Scale (LEFS), and Western Ontario and McMaster University Osteoarthritis Index Physical Function subscale (WOMAC-PF). Responsiveness of physical function was investigated according to the COSMIN standard by testing 15 a priori defined hypotheses formulated by an expert group regarding expected correlations between changes in physical function with changes in other (un)related measures (pain, fatigue, self-efficacy, coping, anxiety, depression and mental health) or expected differences in correlation. Responsiveness was considered positive if > 75% of the hypotheses could be confirmed.

Results:

Of the 161 included patients, the majority was female (61%), with a mean age of 59 years and a body mass index of 29.7 kg/m2. We could confirm 12 out of 15 predefined hypotheses (80%) about expected correlations using the physical function subscale of the WOMAC. For the KOOS-PS, LAI and LEFS respectively 11 (73%), 10 (67%) and 11 (73%) hypotheses could be confirmed.

Conclusion:

This is the first study that evaluated and compared the responsiveness of physical function measured with KOOS-PS, LAI, LEFS and WOMAC-PF according to the latest COSMIN standards1. Our results suggest that the WOMAC-PF is potentially better able to detect changes over time in physical function than the LAI, LEFS and KOOS-PS in a population of patients with knee OA receiving conservative treatment. We therefore recommend the WOMAC-PF subscale should be the measure of first choice in in clinical trials evaluating the effectiveness of an intervention in knee OA patients.


Disclosure: E. A. M. Mahler, None; N. Cuperus, None; J. W. J. Bijlsma, Abbvie, Pfizer, MSD, UCB, BMS, Roche, Crescendo, Multipharma, SUN, 5; T. Vliet Vlieland, None; F. H. J. van den Hoogen, None; A. den Broeder, None; C. H. M. van den Ende, None.

To cite this abstract in AMA style:

Mahler EAM, Cuperus N, Bijlsma JWJ, Vliet Vlieland T, van den Hoogen FHJ, den Broeder A, van den Ende CHM. Assessment and Comparison of Responsiveness of Four Patient Reported Outcome Measures to Assess Physical Function in Patients with Knee Osteoarthritis: WOMAC-PF Subscale Responds Best [abstract]. Arthritis Rheumatol. 2015; 67 (suppl 10). https://acrabstracts.org/abstract/assessment-and-comparison-of-responsiveness-of-four-patient-reported-outcome-measures-to-assess-physical-function-in-patients-with-knee-osteoarthritis-womac-pf-subscale-responds-best/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2015 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/assessment-and-comparison-of-responsiveness-of-four-patient-reported-outcome-measures-to-assess-physical-function-in-patients-with-knee-osteoarthritis-womac-pf-subscale-responds-best/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology